MinorAtypical antipsychotic of the benzamide class×Thyroid hormones
Updated · Methodology
Mechanism
Levothyroxine is almost entirely (about 99.97%) bound to transport proteins and has a half-life of about 7 days. It is metabolised in the liver, kidney, brain and muscle, and the metabolites are excreted in urine and faeces (Eutirox SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). Amisulpride is only slightly metabolised (metabolites account for about 4% of the dose) and is excreted unchanged in the urine (Solian SmPC, AEMPS, section 5.2). The elimination routes do not overlap, and levothyroxine belongs to none of the classes named in the amisulpride SmPC (AEMPS, section 4.5).
Symptoms
The documents describe no symptoms caused by this combination. Like other neuroleptics, amisulpride can cause neuroleptic malignant syndrome with hyperthermia, muscle rigidity, autonomic instability, altered consciousness and raised creatine phosphokinase (Solian SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). Before levothyroxine is started, coronary insufficiency, angina, arteriosclerosis and hypertension are excluded or treated (Eutirox SmPC, AEMPS, section 4.4).
Management
According to the documents, the combination is acceptable and no dose change of levothyroxine or amisulpride is needed. Neither document names the pair, and the drugs are eliminated by different routes (Eutirox and Solian SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, sections 4.5 and 5.2). Amisulpride is prescribed with caution in known cardiovascular disease or a family history of QT prolongation, and concomitant use of other neuroleptics is avoided (Solian SmPC, AEMPS, section 4.4). If signs of neuroleptic malignant syndrome or unexplained hyperthermia appear, antipsychotics, including amisulpride, are stopped (Solian SmPC, AEMPS, section 4.4).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Amisulprida (nº registro 63996), sección 4.4 (2026)– AEMPS, CIMA, nº registro 63996 (Solian 400 mg), revisión 09/2026, secciones 4.3, 4.4, 4.5, 4.8 y 5.1
- AEMPS: Ficha técnica: Levotiroxina, Eutirox 100 microgramos (nº registro 64014), sección 4.5 (2025)– AEMPS, CIMA, nº registro 64014 (Eutirox 100 microgramos comprimidos, Merck; mismo texto de la sección 4.5 en las demás dosis de Eutirox, p. ej. nº 70042 y 64015), revisión 01/2025, sección 4.5